PD-1 regulates neural damage in oligodendroglia-induced inflammation.

We investigated the impact of immune regulatory mechanisms involved in the modulation of the recently presented, CD8+ lymphocyte mediated immune response in a mouse model of oligodendropathy-induced inflammation (PLPtg-mutants). The focus was on the role of the co-inhibitory molecule PD-1, a CD28-re...

Full description

Bibliographic Details
Main Authors: Antje Kroner, Nicholas Schwab, Chi Wang Ip, Christoph Leder, Klaus-Armin Nave, Mathias Mäurer, Heinz Wiendl, Rudolf Martini
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2009-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19197390/?tool=EBI
_version_ 1818839398158958592
author Antje Kroner
Nicholas Schwab
Chi Wang Ip
Christoph Leder
Klaus-Armin Nave
Mathias Mäurer
Heinz Wiendl
Rudolf Martini
author_facet Antje Kroner
Nicholas Schwab
Chi Wang Ip
Christoph Leder
Klaus-Armin Nave
Mathias Mäurer
Heinz Wiendl
Rudolf Martini
author_sort Antje Kroner
collection DOAJ
description We investigated the impact of immune regulatory mechanisms involved in the modulation of the recently presented, CD8+ lymphocyte mediated immune response in a mouse model of oligodendropathy-induced inflammation (PLPtg-mutants). The focus was on the role of the co-inhibitory molecule PD-1, a CD28-related receptor expressed on activated T- and B-lymphocytes associated with immune homeostasis and autoimmunity. PLPtg/PD-1-deficient double mutants and the corresponding bone marrow chimeras were generated and analysed using immunohistochemistry, light- and electron microscopy, with particular emphasis on immune-cell number and neural damage. In addition, the immune cells in both the CNS and the peripheral immune system were investigated by IFN-gamma elispot assays and spectratype analysis. We found that mice with combined pathology exhibited significantly increased numbers of CD4+ and CD8+ T-lymphocytes in the CNS. Lack of PD-1 substantially aggravated the pathological phenotype of the PLPtg mutants compared to genuine PLPtg mutants, whereas the PD-1 deletion alone did not cause alterations in the CNS. CNS T-lymphocytes in PLPtg/PD-1-/- double mutants exhibited massive clonal expansions. Furthermore, PD-1 deficiency was associated with a significantly higher propensity of CNS but not peripheral CD8+ T-cells to secrete proinflammatory cytokines. PD-1 could be identified as a crucial player of tissue homeostasis and immune-mediated damage in a model of oligodendropathy-induced inflammation. Alterations of this regulatory pathway lead to overt neuroinflammation of high pathogenetic impact. Our finding may have implications for understanding the mechanisms leading to the high clinical variability of polygenic or even monogenic disorders of the nervous system.
first_indexed 2024-12-19T03:53:39Z
format Article
id doaj.art-4d4aa06cbc694aa491852a44bf65b1d0
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-19T03:53:39Z
publishDate 2009-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-4d4aa06cbc694aa491852a44bf65b1d02022-12-21T20:36:52ZengPublic Library of Science (PLoS)PLoS ONE1932-62032009-01-0142e440510.1371/journal.pone.0004405PD-1 regulates neural damage in oligodendroglia-induced inflammation.Antje KronerNicholas SchwabChi Wang IpChristoph LederKlaus-Armin NaveMathias MäurerHeinz WiendlRudolf MartiniWe investigated the impact of immune regulatory mechanisms involved in the modulation of the recently presented, CD8+ lymphocyte mediated immune response in a mouse model of oligodendropathy-induced inflammation (PLPtg-mutants). The focus was on the role of the co-inhibitory molecule PD-1, a CD28-related receptor expressed on activated T- and B-lymphocytes associated with immune homeostasis and autoimmunity. PLPtg/PD-1-deficient double mutants and the corresponding bone marrow chimeras were generated and analysed using immunohistochemistry, light- and electron microscopy, with particular emphasis on immune-cell number and neural damage. In addition, the immune cells in both the CNS and the peripheral immune system were investigated by IFN-gamma elispot assays and spectratype analysis. We found that mice with combined pathology exhibited significantly increased numbers of CD4+ and CD8+ T-lymphocytes in the CNS. Lack of PD-1 substantially aggravated the pathological phenotype of the PLPtg mutants compared to genuine PLPtg mutants, whereas the PD-1 deletion alone did not cause alterations in the CNS. CNS T-lymphocytes in PLPtg/PD-1-/- double mutants exhibited massive clonal expansions. Furthermore, PD-1 deficiency was associated with a significantly higher propensity of CNS but not peripheral CD8+ T-cells to secrete proinflammatory cytokines. PD-1 could be identified as a crucial player of tissue homeostasis and immune-mediated damage in a model of oligodendropathy-induced inflammation. Alterations of this regulatory pathway lead to overt neuroinflammation of high pathogenetic impact. Our finding may have implications for understanding the mechanisms leading to the high clinical variability of polygenic or even monogenic disorders of the nervous system.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19197390/?tool=EBI
spellingShingle Antje Kroner
Nicholas Schwab
Chi Wang Ip
Christoph Leder
Klaus-Armin Nave
Mathias Mäurer
Heinz Wiendl
Rudolf Martini
PD-1 regulates neural damage in oligodendroglia-induced inflammation.
PLoS ONE
title PD-1 regulates neural damage in oligodendroglia-induced inflammation.
title_full PD-1 regulates neural damage in oligodendroglia-induced inflammation.
title_fullStr PD-1 regulates neural damage in oligodendroglia-induced inflammation.
title_full_unstemmed PD-1 regulates neural damage in oligodendroglia-induced inflammation.
title_short PD-1 regulates neural damage in oligodendroglia-induced inflammation.
title_sort pd 1 regulates neural damage in oligodendroglia induced inflammation
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19197390/?tool=EBI
work_keys_str_mv AT antjekroner pd1regulatesneuraldamageinoligodendrogliainducedinflammation
AT nicholasschwab pd1regulatesneuraldamageinoligodendrogliainducedinflammation
AT chiwangip pd1regulatesneuraldamageinoligodendrogliainducedinflammation
AT christophleder pd1regulatesneuraldamageinoligodendrogliainducedinflammation
AT klausarminnave pd1regulatesneuraldamageinoligodendrogliainducedinflammation
AT mathiasmaurer pd1regulatesneuraldamageinoligodendrogliainducedinflammation
AT heinzwiendl pd1regulatesneuraldamageinoligodendrogliainducedinflammation
AT rudolfmartini pd1regulatesneuraldamageinoligodendrogliainducedinflammation